Literature DB >> 19917364

Risk factors associated with graft loss and patient survival after kidney transplantation.

K M Harada1, E L Mandia-Sampaio, T V de Sandes-Freitas, C R Felipe, S I Park, P G Pinheiro-Machado, R Garcia, H Tedesco-Silva, J O Medina-Pestana.   

Abstract

OBJECTIVE: To evaluate the influence of traditional risk factors on major kidney transplantation outcome. PATIENTS AND METHODS: Data from kidney transplantation procedures performed between 2003 and 2006 were retrospectively analyzed for the influence of traditional risk factors on transplantation outcome. Of 2364 transplants, 67% were from living donors, 27% were from donors who met standard criteria, and 6% were from donor who met expanded criteria. Two hundred thirty-nine procedures (10%) were performed in pediatric patients. Immunosuppression was selected on the basis of subgroup population.
RESULTS: At 1 year posttransplantation, cumulative freedom from a treated acute rejection episode (ARE) was 76.7%, with no difference between black vs nonblack recipients (75.0% vs 73.4%; P = .79). At 2 years, survival for patients (95.3% vs 88.3% vs 82.1%; P < .001) and grafts 92.3% vs 80.3% vs 70.9%; P < .001) was better in recipients of living donor grafts compared with donors who met standard or expanded criteria, respectively. Moreover, graft survival was poorer in black vs nonblack patients (83.6% vs 88.7%; P < .05) because of high mortality (13% vs 7%; P<.001). Risk factors associated with death included cadaveric donor organ (odds ratio [OR], 2.4) and black race (OR, 1.8), and risk factors associated with graft loss included cadaveric donor organ (OR, 2.1), extended-criteria criteria donor organ (OR, 2.0), delayed graft function (OR, 1.8), and any ARE (OR, 3.5). At 6 months posttransplantation, risk factors associated with death included cadaveric donor organ (OR, 2.5) or ARE (OR, 2.4), and risk factors associated with graft loss included cadaveric donor organ (OR, 2.0), extended-criteria donor organ (OR, 2.6), ARE (OR, 9.5), and impaired graft function (creatinine concentration >1.5 mg/dL; OR, 2.1).
CONCLUSION: Traditional risk factors are still associated with transplantation outcome. Poorer graft survival in black vs nonblack recipients was due to higher mortality rather than graft loss.

Entities:  

Mesh:

Year:  2009        PMID: 19917364     DOI: 10.1016/j.transproceed.2009.04.013

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  19 in total

Review 1.  Tissue engineering and regenerative medicine research perspectives for pediatric surgery.

Authors:  Amulya K Saxena
Journal:  Pediatr Surg Int       Date:  2010-03-24       Impact factor: 1.827

2.  Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17.

Authors:  Geovani Faddoul; Girish N Nadkarni; Nancy D Bridges; Jens Goebel; Donald E Hricik; Richard Formica; Madhav C Menon; Yvonne Morrison; Barbara Murphy; Kenneth Newell; Peter Nickerson; Emilio D Poggio; David Rush; Peter S Heeger
Journal:  Transplantation       Date:  2018-04       Impact factor: 4.939

3.  A Single-center, Retrospective Study of Focal Segmental Glomerulosclerosis after Kidney Transplantation: Evolutive Analysis.

Authors:  G Ferreira da Mata; J B Mansur; M T P Riguetti; G F Rezende; J Osmar de Medina Pestana; G Mastroianni Kirsztajn
Journal:  Int J Organ Transplant Med       Date:  2021

4.  Association of vitamin D binding protein polymorphism with long-term kidney allograft survival in Hispanic kidney transplant recipients.

Authors:  Don Vu; Prashant Sakharkar; Eglis Tellez-Corrales; Tariq Shah; Ian Hutchinson; David I Min
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

5.  Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.

Authors:  Pamala A Jacobson; David Schladt; Ajay Israni; William S Oetting; Yi Cheng Lin; Robert Leduc; Weihau Guan; Vishal Lamba; Arthur J Matas
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

6.  Incidence of malignancy after living kidney transplantation: a multicenter study from iran.

Authors:  Behzad Einollahi; Zohreh Rostami; Mohammad Hossein Nourbala; Mahboob Lessan-Pezeshki; Naser Simforoosh; Eghlim Nemati; Vahid Pourfarziani; Fatemeh Beiraghdar; Mohsen Nafar; Fatemeh Pour-Reza-Gholi; Mitra Mahdavi Mazdeh; Manochehr Amini; Pedram Ahmadpour; Khadijeh Makhdoomi; Ali Ghafari; Mohammad Reza Ardalan; Hamid Taebi Khosroshahi; Farshid Oliaei; Shahrzad Shahidi; Shahin Abbaszadeh; Mohammad Reza Fatahi; Fatemeh Hiedari; Atehieh Makhlogh; Jalal Azmandian; Hamid Reza Samimagham; Heshmatollah Shahbazian; Fatemeh Nazemian; Massih Naghibi; Masoud Khosravi; Ali Monfared; Seyed Majid Mosavi; Javad Ahmadi; Mojgan Jalalzadeh
Journal:  J Cancer       Date:  2012-06-05       Impact factor: 4.207

7.  The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome.

Authors:  Mojgan Jalalzadeh; Nouraddin Mousavinasab; Said Peyrovi; Mohammad Hassan Ghadiani
Journal:  Nephrourol Mon       Date:  2015-01-20

8.  Derivation of a Predictive Model for Graft Loss Following Acute Kidney Injury in Kidney Transplant Recipients.

Authors:  Amber O Molnar; Carl van Walraven; Dean Fergusson; Amit X Garg; Greg Knoll
Journal:  Can J Kidney Health Dis       Date:  2017-01-30

9.  Chronic graft loss and death in patients with post-transplant malignancy in living kidney transplantation: a competing risk analysis.

Authors:  Mahmoud Salesi; Zohreh Rostami; Abbas Rahimi Foroushani; Ali Reza Mehrazmay; Jamile Mohammadi; Behzad Einollahi; Saeed Asgharian; Mohammad Reza Eshraghian
Journal:  Nephrourol Mon       Date:  2014-03-10

10.  Risk Factors of Graft Survival After Diagnosis of Post-kidney Transplant Malignancy: Using Cox Proportional Hazard Model.

Authors:  Abbas Rahimi Foroushani; Mahmoud Salesi; Zohreh Rostami; Ali Reza Mehrazmay; Jamile Mohammadi; Behzad Einollahi; Mohammad Reza Eshraghian
Journal:  Iran Red Crescent Med J       Date:  2015-11-14       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.